
TEOSYAL Deep LInes is part of the Teosyal range of dermal fillers that uses highly purified hyaluronic acid. The product is specifically formulated for the treatment of deep wrinkles and nasolabial folds, as well as enhancing volume in areas that have lost fullness due to aging. Its smooth, injectable gel restores the skin’s youthful appearance and provides volume with long-lasting results. Thanks to its strong cohesiveness, it delivers reliable filling capacity while maintaining natural facial expressions.
Main Treatment Areas
The primary areas treated with TEOSYAL DEEP LINES include nasolabial folds, marionette lines, and deep forehead wrinkles. It can also be used for chin augmentation, cheek volumization, and contouring facial areas that have experienced significant loss of volume over time. These deep wrinkles often result from skin sagging and loss of elasticity, and TEOSYAL DEEP LINES effectively fills and smooths these areas for a rejuvenated appearance.
Key Benefits
- Long-lasting results: TEOSYAL DEEP LINES provides up to 9 to 12 months of durable results.
- Natural appearance: Its high cohesiveness ensures it integrates seamlessly into the skin, delivering natural facial volume without overfilling.
- Non-invasive: As a dermal filler, this treatment provides a non-surgical alternative to address signs of aging, offering patients effective wrinkle reduction without downtime.
- Hyaluronic acid formulation: As a highly biocompatible substance, it is well-tolerated and safe for a variety of skin types.
Safety Information
TEOSYAL Deep LInes is generally well-tolerated but should only be administered by licensed healthcare professionals. Patients might experience temporary swelling, redness, or bruising at the injection sites, which usually resolves within a few days. It is not recommended for individuals with allergies to hyaluronic acid or those with active skin infections in the treatment area. Always consult with a medical provider to ensure suitability before treatment.










Reviews
There are no reviews yet.